 |
|
Faculty
Brown, Stuart I. MD
Brody, Barbara MPH
Ferreyra, Henry
A. MD
Freeman, William
R. MD
Goldbaum, Michael
H. MD
Granet, David B. MD
Haw,
Weldon, MD
Heichel, Chris MD
Kikkawa, Don O. MD
Korn, Bobby S. MD, PhD
Levi, Leah MD
Medeiros, Felipe
MD PhD
Nguyen, Thao MD
Robbins, Shira MD
Savino, Peter J. MD
Schanzlin, David
J. MD
Weinreb, Robert N.
MD Zhang, Kang MD, PhD
Research Faculty
Ayyagari, Radha PhD
Bartsch,
Dirk- Uwe PhD
Lindsey, James D. PhD
Liu, John H K PhD
Sample, Pamela A.
PhD
Silva, Gabriel A. MSc
PhD
Zangwill, Linda
PhD
Research Scientist
Bowd, Christoper PhD
Cheng, Lingyun MD
Duncan, Robert PhD
Ju, Won-Kyu PhD
Kozak, Igor MD, PhD
Vasireddy, Vidyullatha PhD
|
| |
|
 |
| |
Henry
A. Ferreyra, M.D.
Assistant Clinical Professor
|
|
Henry
A. Ferreyra, M.D. is an Assistant Clinical Professor
with the UCSD Department of Ophthalmology at the Shiley
Eye Center. His early interest in the molecular basis
of disease led him to major in Molecular and Cell Biology
at the University of California, Berkeley. He obtained
his medical degree from the University of California,
San Diego. After medical school, he did a general surgery
internship at the University of California, San Francisco.
His interest in microsurgery led him to complete a residency
in ophthalmology and fellowship in vitreoretinal diseases
at the University of California, San Diego. Dr. Ferreyra
then studied electroretinography and retinal dystrophies
at the University of Michigan with Dr. John Heckenlively,
an internationally renowned authority in the field.
Dr.
Ferreyra has diverse clinical interests ranging from
age-related macular degeneration to retinopathy of prematurity.
In the fall of 2007, Dr. Ferreyra will found and direct
the Retinal Dystrophy Clinic at the Shiley Eye Center,
making it the only such clinic in the San Diego area.
The clinic will integrate electrophysiological studies
with the most advanced imaging technologies. Like others
in the field, he believes that our increasing understanding
of the molecular and genetic basis of retinal diseases
will allow gene therapy and stem cells to be used to
treat conditions like retinitis pigmentosa, and even
macular degeneration.
In addition to his clinical practice, Dr. Ferreyra is
an active researcher and has published numerous peer-reviewed
articles. Dr. Ferreyra is an investigator in the Age-Related
Eye Disease Study 2 (AREDS 2), a multi-center clinic
trial studying the benefits of lutein and docosahexaenoic
acid (DHA) for AMD. Dr. Ferreyra recently appeared on
San Diego’s NBC affiliate KNSD discussing routine
eye care. He was the recipient of the Pan American Association
of Ophthalmology International Travel Scholar Award
and was awarded the Outstanding Teaching Award by the
ophthalmology residents.
Dr.
Ferreyra is bilingual in Spanish, a skill appreciated
by his Spanish-speaking patients. In addition to his
clinical work, Dr. Ferreyra believes in giving back
to the community. He has worked with under-represented
students interested in pursuing a medical career by
mentoring them and starting a clinical preceptor program
with the Post-Baccalaureate program.
|
|